scRNA-seq landscape in responsive and non-responsive HCC patients treated with anti-PD-1 therapy reveals a significant accumulation of TREM2+ macrophages in non-responsive samples, while TCR+ macrophages exhibit tumor-killing capacity[41]. The gene discussed is TREM2; the disease is neoplasm.